These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25663875)

  • 41. Immune independent crosstalk between lymphoma and myeloid suppressor CD14
    Zhang ZJ; Bulur PA; Dogan A; Gastineau DA; Dietz AB; Lin Y
    Oncoimmunology; 2015 Apr; 4(4):e996470. PubMed ID: 26137410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.
    García-Álvarez M; Alcoceba M; López-Parra M; Puig N; Antón A; Balanzategui A; Prieto-Conde I; Jiménez C; Sarasquete ME; Chillón MC; Gutiérrez ML; Corral R; Alonso JM; Queizán JA; Vidán J; Pardal E; Peñarrubia MJ; Bastida JM; García-Sanz R; Marín L; González M
    PLoS One; 2017; 12(3):e0172978. PubMed ID: 28249016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.
    Mayr C; Bund D; Schlee M; Bamberger M; Kofler DM; Hallek M; Wendtner CM
    Exp Hematol; 2006 Jan; 34(1):44-53. PubMed ID: 16413390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proposals for a Phenotypic Classification of B-Chronic Lymphocytic Leukemia, Relationship with Prognostic Factors.
    Legac E; Chastang C; Binet JL; Michel A; Debre P; Merle-Beral H
    Leuk Lymphoma; 1991; 5 Suppl 1():53-8. PubMed ID: 27463480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
    Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
    J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia.
    Tobe H; Ruether BA; Jerry LM; Tamaoki T
    Cancer Biochem Biophys; 1986 Oct; 8(4):313-26. PubMed ID: 3492264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
    Roliński J; Rupniewska ZM; Wasik-Szczepanek E
    Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Definition of a target for immunotherapy and results of the first Peptide vaccination study in chronic lymphocytic leukemia.
    Tabarkiewicz J; Giannopoulos K
    Transplant Proc; 2010 Oct; 42(8):3293-6. PubMed ID: 20970674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of HLA-G gene expression in B-lymphocytes from chronic lymphocytic leukemia patients.
    Rezvany MR; Kazemi A; Hajifathali A; Kaviani S; Mellstedt H
    Iran Biomed J; 2007 Apr; 11(2):125-129. PubMed ID: 18051955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia.
    Wagner B; da Silva Nardi F; Schramm S; Kraemer T; Celik AA; Dürig J; Horn PA; Dührsen U; Nückel H; Rebmann V
    Cancer; 2017 Mar; 123(5):814-823. PubMed ID: 27859015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
    Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
    Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immune function of myeloid-derived suppressor cells and its mechanism in obstructive sleep apnea syndrome].
    Chen SW; Li J; Xiang B; Xu SJ; Wang L
    Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):295-300. PubMed ID: 32075359
    [No Abstract]   [Full Text] [Related]  

  • 57. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
    Hanna BS; Öztürk S; Seiffert M
    Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of CD5 Membrane Expression on B-Chronic Lymphocytic Leukemia Cells.
    Kay NE; Peterson L
    Leuk Lymphoma; 1991; 5(1):49-55. PubMed ID: 27463209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
    Strati P; Caligaris-Cappio F
    Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.